COVID Vaccine Less Effective in Children

In kids aged 5 to 11 years, Pfizer's COVID vaccine is found to be significantly less effective than in older adolescents or adults.

The yet to be peer-reviewed study, led by The New York State Department of Health, found that during the Omicron era, the effectiveness of the Pfizer-BioNTech Covid vaccine declined rapidly -- from 68 per cent to 12 per cent for children aged 5-11 years.

COVID in Children | Guidelines for Management of COVID-19 in Children
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.

‘The study supports vaccine protection against severe disease among children 5-11 years, but suggests rapid loss of protection against infection, in the Omicron variant era.’

Vaccine efficacy also declined from 66 per cent to 51 per cent for those between 12 and 17 years.

Although vaccination was found protective against severe disease the efficacy against hospitalization also declined from 85 per cent to 73 per cent for children aged between 12 and 17 years, and from 100 per cent to 48 per cent for those aged between 5 and 11 years.

The difference in effectiveness may be explained by "lower vaccine dose", said the researchers.

COVID Vaccines Destroyed Over Fears of Blood Clot Risk
In the United Kingdom, about 4.7 million COVID vaccine doses were wasted amid concerns of over blood clot risk, revealed sources.

Compared to children 12-17 years, who received two 30g doses,children 5-11 years, received two 10g doses.

The study examined Pfizer vaccine effectiveness from December 13, 2021 to January 30, 2022, among 852,384 fully-vaccinated children 12-17 years and 365,502 children 5-11 years.

Two New Covid Vaccines and 1 Anti-Viral Drug Approved by CDSCO
Omicron variant cases are rising in the country and two new Covid-19 vaccines have been approved by the Central Drugs Standard Control Organization (CDSCO).

Among children 12-17, protection declined substantially, albeit more slowly than observed among younger children.

Within just two weeks of full vaccination the efficacy for children aged 5-11 dropped to 65 per cent and by 28-34 days it was 12 per cent

COVID Vaccines Lower Risk of Infection With Delta Variant
Study of 621 people in the UK with mild COVID-19 infections found that people who received two vaccine doses could still pass the infection on to vaccinated and unvaccinated household members.

For children between 12-17 years, effectiveness declined from 76 per cent to 56 per cent by 28-34 days.

"These results highlight the potential need to study alternative vaccine dosing for children and the continued importance of layered protections, including mask wearing, to prevent infection and transmission," she added.

The study comes as several states and the US Centers for Disease Control and Prevention have eased the mask restrictions.

Source-IANS